Report Overview
Nuclear Drugs are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis
The global Diagnostic Nuclear Drug market size was estimated at USD 4722 million in 2023 and is projected to reach USD 8608.46 million by 2032, exhibiting a CAGR of 6.90% during the forecast period.
North America Diagnostic Nuclear Drug market size was estimated at USD 1380.26 million in 2023, at a CAGR of 5.91% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Diagnostic Nuclear Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Diagnostic Nuclear Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Diagnostic Nuclear Drug market in any manner.
Global Diagnostic Nuclear Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Novartis
SIEMENS
China Isotope & Radiation
Dongcheng
Lantheus
Eli Lilly
Market Segmentation (by Type)
Tc-99m
F-18
Other
Market Segmentation (by Application)
Oncology
Cardiology
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Diagnostic Nuclear Drug Market
Overview of the regional outlook of the Diagnostic Nuclear Drug Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Diagnostic Nuclear Drug
1.2 Key Market Segments
1.2.1 Diagnostic Nuclear Drug Segment by Type
1.2.2 Diagnostic Nuclear Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Diagnostic Nuclear Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Diagnostic Nuclear Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Diagnostic Nuclear Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Diagnostic Nuclear Drug Market Competitive Landscape
3.1 Global Diagnostic Nuclear Drug Sales by Manufacturers (2019-2025)
3.2 Global Diagnostic Nuclear Drug Revenue Market Share by Manufacturers (2019-2025)
3.3 Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Diagnostic Nuclear Drug Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Diagnostic Nuclear Drug Sales Sites, Area Served, Product Type
3.6 Diagnostic Nuclear Drug Market Competitive Situation and Trends
3.6.1 Diagnostic Nuclear Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Diagnostic Nuclear Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Diagnostic Nuclear Drug Industry Chain Analysis
4.1 Diagnostic Nuclear Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Diagnostic Nuclear Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Diagnostic Nuclear Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Diagnostic Nuclear Drug Sales Market Share by Type (2019-2025)
6.3 Global Diagnostic Nuclear Drug Market Size Market Share by Type (2019-2025)
6.4 Global Diagnostic Nuclear Drug Price by Type (2019-2025)
7 Diagnostic Nuclear Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Diagnostic Nuclear Drug Market Sales by Application (2019-2025)
7.3 Global Diagnostic Nuclear Drug Market Size (M USD) by Application (2019-2025)
7.4 Global Diagnostic Nuclear Drug Sales Growth Rate by Application (2019-2025)
8 Diagnostic Nuclear Drug Market Consumption by Region
8.1 Global Diagnostic Nuclear Drug Sales by Region
8.1.1 Global Diagnostic Nuclear Drug Sales by Region
8.1.2 Global Diagnostic Nuclear Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Diagnostic Nuclear Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Diagnostic Nuclear Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Diagnostic Nuclear Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Diagnostic Nuclear Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Diagnostic Nuclear Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Diagnostic Nuclear Drug Market Production by Region
9.1 Global Production of Diagnostic Nuclear Drug by Region (2019-2025)
9.2 Global Diagnostic Nuclear Drug Revenue Market Share by Region (2019-2025)
9.3 Global Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Diagnostic Nuclear Drug Production
9.4.1 North America Diagnostic Nuclear Drug Production Growth Rate (2019-2025)
9.4.2 North America Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Diagnostic Nuclear Drug Production
9.5.1 Europe Diagnostic Nuclear Drug Production Growth Rate (2019-2025)
9.5.2 Europe Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Diagnostic Nuclear Drug Production (2019-2025)
9.6.1 Japan Diagnostic Nuclear Drug Production Growth Rate (2019-2025)
9.6.2 Japan Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Diagnostic Nuclear Drug Production (2019-2025)
9.7.1 China Diagnostic Nuclear Drug Production Growth Rate (2019-2025)
9.7.2 China Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Cardinal Health
10.1.1 Cardinal Health Diagnostic Nuclear Drug Basic Information
10.1.2 Cardinal Health Diagnostic Nuclear Drug Product Overview
10.1.3 Cardinal Health Diagnostic Nuclear Drug Product Market Performance
10.1.4 Cardinal Health Business Overview
10.1.5 Cardinal Health Diagnostic Nuclear Drug SWOT Analysis
10.1.6 Cardinal Health Recent Developments
10.2 GE Healthcare
10.2.1 GE Healthcare Diagnostic Nuclear Drug Basic Information
10.2.2 GE Healthcare Diagnostic Nuclear Drug Product Overview
10.2.3 GE Healthcare Diagnostic Nuclear Drug Product Market Performance
10.2.4 GE Healthcare Business Overview
10.2.5 GE Healthcare Diagnostic Nuclear Drug SWOT Analysis
10.2.6 GE Healthcare Recent Developments
10.3 Curium Pharma
10.3.1 Curium Pharma Diagnostic Nuclear Drug Basic Information
10.3.2 Curium Pharma Diagnostic Nuclear Drug Product Overview
10.3.3 Curium Pharma Diagnostic Nuclear Drug Product Market Performance
10.3.4 Curium Pharma Diagnostic Nuclear Drug SWOT Analysis
10.3.5 Curium Pharma Business Overview
10.3.6 Curium Pharma Recent Developments
10.4 Jubilant Pharma
10.4.1 Jubilant Pharma Diagnostic Nuclear Drug Basic Information
10.4.2 Jubilant Pharma Diagnostic Nuclear Drug Product Overview
10.4.3 Jubilant Pharma Diagnostic Nuclear Drug Product Market Performance
10.4.4 Jubilant Pharma Business Overview
10.4.5 Jubilant Pharma Recent Developments
10.5 Bracco Imaging
10.5.1 Bracco Imaging Diagnostic Nuclear Drug Basic Information
10.5.2 Bracco Imaging Diagnostic Nuclear Drug Product Overview
10.5.3 Bracco Imaging Diagnostic Nuclear Drug Product Market Performance
10.5.4 Bracco Imaging Business Overview
10.5.5 Bracco Imaging Recent Developments
10.6 Novartis
10.6.1 Novartis Diagnostic Nuclear Drug Basic Information
10.6.2 Novartis Diagnostic Nuclear Drug Product Overview
10.6.3 Novartis Diagnostic Nuclear Drug Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 SIEMENS
10.7.1 SIEMENS Diagnostic Nuclear Drug Basic Information
10.7.2 SIEMENS Diagnostic Nuclear Drug Product Overview
10.7.3 SIEMENS Diagnostic Nuclear Drug Product Market Performance
10.7.4 SIEMENS Business Overview
10.7.5 SIEMENS Recent Developments
10.8 China Isotope and Radiation
10.8.1 China Isotope and Radiation Diagnostic Nuclear Drug Basic Information
10.8.2 China Isotope and Radiation Diagnostic Nuclear Drug Product Overview
10.8.3 China Isotope and Radiation Diagnostic Nuclear Drug Product Market Performance
10.8.4 China Isotope and Radiation Business Overview
10.8.5 China Isotope and Radiation Recent Developments
10.9 Dongcheng
10.9.1 Dongcheng Diagnostic Nuclear Drug Basic Information
10.9.2 Dongcheng Diagnostic Nuclear Drug Product Overview
10.9.3 Dongcheng Diagnostic Nuclear Drug Product Market Performance
10.9.4 Dongcheng Business Overview
10.9.5 Dongcheng Recent Developments
10.10 Lantheus
10.10.1 Lantheus Diagnostic Nuclear Drug Basic Information
10.10.2 Lantheus Diagnostic Nuclear Drug Product Overview
10.10.3 Lantheus Diagnostic Nuclear Drug Product Market Performance
10.10.4 Lantheus Business Overview
10.10.5 Lantheus Recent Developments
10.11 Eli Lilly
10.11.1 Eli Lilly Diagnostic Nuclear Drug Basic Information
10.11.2 Eli Lilly Diagnostic Nuclear Drug Product Overview
10.11.3 Eli Lilly Diagnostic Nuclear Drug Product Market Performance
10.11.4 Eli Lilly Business Overview
10.11.5 Eli Lilly Recent Developments
11 Diagnostic Nuclear Drug Market Forecast by Region
11.1 Global Diagnostic Nuclear Drug Market Size Forecast
11.2 Global Diagnostic Nuclear Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Diagnostic Nuclear Drug Market Size Forecast by Country
11.2.3 Asia Pacific Diagnostic Nuclear Drug Market Size Forecast by Region
11.2.4 South America Diagnostic Nuclear Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Diagnostic Nuclear Drug by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Diagnostic Nuclear Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Diagnostic Nuclear Drug by Type (2025-2032)
12.1.2 Global Diagnostic Nuclear Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Diagnostic Nuclear Drug by Type (2025-2032)
12.2 Global Diagnostic Nuclear Drug Market Forecast by Application (2025-2032)
12.2.1 Global Diagnostic Nuclear Drug Sales (K MT) Forecast by Application
12.2.2 Global Diagnostic Nuclear Drug Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Diagnostic Nuclear Drug Market Size Comparison by Region (M USD)
Table 5. Global Diagnostic Nuclear Drug Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Diagnostic Nuclear Drug Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Diagnostic Nuclear Drug Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Diagnostic Nuclear Drug Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Nuclear Drug as of 2022)
Table 10. Global Market Diagnostic Nuclear Drug Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Diagnostic Nuclear Drug Sales Sites and Area Served
Table 12. Manufacturers Diagnostic Nuclear Drug Product Type
Table 13. Global Diagnostic Nuclear Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Diagnostic Nuclear Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Diagnostic Nuclear Drug Market Challenges
Table 22. Global Diagnostic Nuclear Drug Sales by Type (K MT)
Table 23. Global Diagnostic Nuclear Drug Market Size by Type (M USD)
Table 24. Global Diagnostic Nuclear Drug Sales (K MT) by Type (2019-2025)
Table 25. Global Diagnostic Nuclear Drug Sales Market Share by Type (2019-2025)
Table 26. Global Diagnostic Nuclear Drug Market Size (M USD) by Type (2019-2025)
Table 27. Global Diagnostic Nuclear Drug Market Size Share by Type (2019-2025)
Table 28. Global Diagnostic Nuclear Drug Price (USD/MT) by Type (2019-2025)
Table 29. Global Diagnostic Nuclear Drug Sales (K MT) by Application
Table 30. Global Diagnostic Nuclear Drug Market Size by Application
Table 31. Global Diagnostic Nuclear Drug Sales by Application (2019-2025) & (K MT)
Table 32. Global Diagnostic Nuclear Drug Sales Market Share by Application (2019-2025)
Table 33. Global Diagnostic Nuclear Drug Sales by Application (2019-2025) & (M USD)
Table 34. Global Diagnostic Nuclear Drug Market Share by Application (2019-2025)
Table 35. Global Diagnostic Nuclear Drug Sales Growth Rate by Application (2019-2025)
Table 36. Global Diagnostic Nuclear Drug Sales by Region (2019-2025) & (K MT)
Table 37. Global Diagnostic Nuclear Drug Sales Market Share by Region (2019-2025)
Table 38. North America Diagnostic Nuclear Drug Sales by Country (2019-2025) & (K MT)
Table 39. Europe Diagnostic Nuclear Drug Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Diagnostic Nuclear Drug Sales by Region (2019-2025) & (K MT)
Table 41. South America Diagnostic Nuclear Drug Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Diagnostic Nuclear Drug Sales by Region (2019-2025) & (K MT)
Table 43. Global Diagnostic Nuclear Drug Production (K MT) by Region (2019-2025)
Table 44. Global Diagnostic Nuclear Drug Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Diagnostic Nuclear Drug Revenue Market Share by Region (2019-2025)
Table 46. Global Diagnostic Nuclear Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Diagnostic Nuclear Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Diagnostic Nuclear Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Diagnostic Nuclear Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Diagnostic Nuclear Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Cardinal Health Diagnostic Nuclear Drug Basic Information
Table 52. Cardinal Health Diagnostic Nuclear Drug Product Overview
Table 53. Cardinal Health Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Cardinal Health Business Overview
Table 55. Cardinal Health Diagnostic Nuclear Drug SWOT Analysis
Table 56. Cardinal Health Recent Developments
Table 57. GE Healthcare Diagnostic Nuclear Drug Basic Information
Table 58. GE Healthcare Diagnostic Nuclear Drug Product Overview
Table 59. GE Healthcare Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. GE Healthcare Business Overview
Table 61. GE Healthcare Diagnostic Nuclear Drug SWOT Analysis
Table 62. GE Healthcare Recent Developments
Table 63. Curium Pharma Diagnostic Nuclear Drug Basic Information
Table 64. Curium Pharma Diagnostic Nuclear Drug Product Overview
Table 65. Curium Pharma Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Curium Pharma Diagnostic Nuclear Drug SWOT Analysis
Table 67. Curium Pharma Business Overview
Table 68. Curium Pharma Recent Developments
Table 69. Jubilant Pharma Diagnostic Nuclear Drug Basic Information
Table 70. Jubilant Pharma Diagnostic Nuclear Drug Product Overview
Table 71. Jubilant Pharma Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Jubilant Pharma Business Overview
Table 73. Jubilant Pharma Recent Developments
Table 74. Bracco Imaging Diagnostic Nuclear Drug Basic Information
Table 75. Bracco Imaging Diagnostic Nuclear Drug Product Overview
Table 76. Bracco Imaging Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Bracco Imaging Business Overview
Table 78. Bracco Imaging Recent Developments
Table 79. Novartis Diagnostic Nuclear Drug Basic Information
Table 80. Novartis Diagnostic Nuclear Drug Product Overview
Table 81. Novartis Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Novartis Business Overview
Table 83. Novartis Recent Developments
Table 84. SIEMENS Diagnostic Nuclear Drug Basic Information
Table 85. SIEMENS Diagnostic Nuclear Drug Product Overview
Table 86. SIEMENS Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. SIEMENS Business Overview
Table 88. SIEMENS Recent Developments
Table 89. China Isotope and Radiation Diagnostic Nuclear Drug Basic Information
Table 90. China Isotope and Radiation Diagnostic Nuclear Drug Product Overview
Table 91. China Isotope and Radiation Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. China Isotope and Radiation Business Overview
Table 93. China Isotope and Radiation Recent Developments
Table 94. Dongcheng Diagnostic Nuclear Drug Basic Information
Table 95. Dongcheng Diagnostic Nuclear Drug Product Overview
Table 96. Dongcheng Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Dongcheng Business Overview
Table 98. Dongcheng Recent Developments
Table 99. Lantheus Diagnostic Nuclear Drug Basic Information
Table 100. Lantheus Diagnostic Nuclear Drug Product Overview
Table 101. Lantheus Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Lantheus Business Overview
Table 103. Lantheus Recent Developments
Table 104. Eli Lilly Diagnostic Nuclear Drug Basic Information
Table 105. Eli Lilly Diagnostic Nuclear Drug Product Overview
Table 106. Eli Lilly Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Recent Developments
Table 109. Global Diagnostic Nuclear Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 110. Global Diagnostic Nuclear Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 111. North America Diagnostic Nuclear Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 112. North America Diagnostic Nuclear Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 113. Europe Diagnostic Nuclear Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 114. Europe Diagnostic Nuclear Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 115. Asia Pacific Diagnostic Nuclear Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 116. Asia Pacific Diagnostic Nuclear Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 117. South America Diagnostic Nuclear Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 118. South America Diagnostic Nuclear Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 119. Middle East and Africa Diagnostic Nuclear Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 120. Middle East and Africa Diagnostic Nuclear Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 121. Global Diagnostic Nuclear Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 122. Global Diagnostic Nuclear Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 123. Global Diagnostic Nuclear Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 124. Global Diagnostic Nuclear Drug Sales (K MT) Forecast by Application (2025-2032)
Table 125. Global Diagnostic Nuclear Drug Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Diagnostic Nuclear Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Diagnostic Nuclear Drug Market Size (M USD), 2019-2032
Figure 5. Global Diagnostic Nuclear Drug Market Size (M USD) (2019-2032)
Figure 6. Global Diagnostic Nuclear Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Diagnostic Nuclear Drug Market Size by Country (M USD)
Figure 11. Diagnostic Nuclear Drug Sales Share by Manufacturers in 2023
Figure 12. Global Diagnostic Nuclear Drug Revenue Share by Manufacturers in 2023
Figure 13. Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Diagnostic Nuclear Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Diagnostic Nuclear Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Diagnostic Nuclear Drug Market Share by Type
Figure 18. Sales Market Share of Diagnostic Nuclear Drug by Type (2019-2025)
Figure 19. Sales Market Share of Diagnostic Nuclear Drug by Type in 2023
Figure 20. Market Size Share of Diagnostic Nuclear Drug by Type (2019-2025)
Figure 21. Market Size Market Share of Diagnostic Nuclear Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Diagnostic Nuclear Drug Market Share by Application
Figure 24. Global Diagnostic Nuclear Drug Sales Market Share by Application (2019-2025)
Figure 25. Global Diagnostic Nuclear Drug Sales Market Share by Application in 2023
Figure 26. Global Diagnostic Nuclear Drug Market Share by Application (2019-2025)
Figure 27. Global Diagnostic Nuclear Drug Market Share by Application in 2023
Figure 28. Global Diagnostic Nuclear Drug Sales Growth Rate by Application (2019-2025)
Figure 29. Global Diagnostic Nuclear Drug Sales Market Share by Region (2019-2025)
Figure 30. North America Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Diagnostic Nuclear Drug Sales Market Share by Country in 2023
Figure 32. U.S. Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Diagnostic Nuclear Drug Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Diagnostic Nuclear Drug Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Diagnostic Nuclear Drug Sales Market Share by Country in 2023
Figure 37. Germany Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Diagnostic Nuclear Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Diagnostic Nuclear Drug Sales Market Share by Region in 2023
Figure 44. China Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Diagnostic Nuclear Drug Sales and Growth Rate (K MT)
Figure 50. South America Diagnostic Nuclear Drug Sales Market Share by Country in 2023
Figure 51. Brazil Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Diagnostic Nuclear Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Diagnostic Nuclear Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Diagnostic Nuclear Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Diagnostic Nuclear Drug Production Market Share by Region (2019-2025)
Figure 62. North America Diagnostic Nuclear Drug Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Diagnostic Nuclear Drug Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Diagnostic Nuclear Drug Production (K MT) Growth Rate (2019-2025)
Figure 65. China Diagnostic Nuclear Drug Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Diagnostic Nuclear Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Diagnostic Nuclear Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Diagnostic Nuclear Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Diagnostic Nuclear Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global Diagnostic Nuclear Drug Sales Forecast by Application (2025-2032)
Figure 71. Global Diagnostic Nuclear Drug Market Share Forecast by Application (2025-2032)
